Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

See our complete portfolio of awards below.

View Funded Institutions
View Funded Investigators
Find Clinical Trials

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of Southern California Dr. Robert E Maxson Training Grant I-1 CIRM Stem Cell Biology Training Grant $2,332,431
University of California, Irvine Dr. Peter Bryant Training Grant I-1 Stem Cell Research Training Grant $1,935,487
University of California, Berkeley Randy W. Schekman Training Grant I-1 Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland $2,360,457
University of California, San Diego Dr. Lawrence S. B. Goldstein Training Grant I-1 Interdisciplinary Stem Cell Training Program at UCSD $3,459,396
Stanford University Dr Michael T Longaker Training Grant I-1 Stanford CIRM Training Program $3,035,282
University of California, Davis Mehrdad Abedi Disease Team Therapy Planning I Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients $66,880
University of California, Davis Dr. John Laird Disease Team Therapy Planning I Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia $76,066
University of California, Davis Dr. Vicki Wheelock Disease Team Therapy Planning I MSC engineered to produce BDNF for the treatment of Huntington’s disease $97,564
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Disease Team Therapy Planning I Stem Cells Secreting GDNF for the Treatment of ALS $63,487
Stanford University Dr. Albert J Wong Disease Team Therapy Planning I Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma $109,750
Stanford University Dr. Judith A Shizuru Disease Team Therapy Planning I A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $90,147
OncoMed Pharmaceuticals, Inc. Timothy Hoey Disease Team Therapy Planning I Anti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency $65,120
Cedars-Sinai Medical Center Dr. Dan Gazit Disease Team Therapy Planning I Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. $107,622
StemCells, Inc. Dr. Alexandra Capela Disease Team Therapy Planning I Neuroprotection to treat Alzheimer’s: a new paradigm using human central nervous system cells $90,101
University of California, Los Angeles Dr. Stanley Nelson Disease Team Therapy Planning I Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy $68,947
Geron Corporation Dr. Jane Stephanie Lebkowski Dr. Disease Team Therapy Planning I Preclinical Development and First-In-Human Testing of GRNCM1 in Advanced Heart Failure $0
Sanford Burnham Prebys Medical Discovery Institute Dr. Marcel Daadi Dr. Disease Team Therapy Planning I Neural Stem Cell-Based Therapy For Parkinson’s Disease $63,952
Sanford Burnham Prebys Medical Discovery Institute Dr. Stuart A Lipton Disease Team Therapy Planning I hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease $96,448
University of California, Davis Nancy E. Lane Disease Team Therapy Planning I Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis $107,750
University of Southern California Roberta Diaz Brinton Disease Team Therapy Planning I A CIRM Disease Team to Develop Allopregnanolone for Prevention and Treatment of Alzheimer’s Disease $107,961
Samumed, LLC John Hood Disease Team Therapy Planning I Clinical Development of an osteoinductive therapy to prevent osteoporosis-related fractures $99,110
Stanford University Dr. Robert Robbins Disease Team Therapy Planning I Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $73,030
University of California, Davis Dr. Martin Birchall Disease Team Therapy Planning I Airways for Children $19,800
University of California, Los Angeles Dr. Antoni Ribas MD/PhD Disease Team Therapy Planning I Genetic Re-programming of Stem Cells to Fight Cancer $97,785
University of California, San Diego Armin Blesch Progression Award – Discovery Stage Research Projects Simplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury $180,000
Stanford University Dr. Helen M Blau Progression Award – Discovery Stage Research Projects Stimulating endogenous muscle stem cells to counter muscle wasting $237,060
University of California, Irvine Dr. Brian J. Cummings Progression Award – Discovery Stage Research Projects Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI) $202,667
University of California, Berkeley Kevin E. Healy Progression Award – Discovery Stage Research Projects Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy $224,500
University of California, Los Angeles Dr. Caroline Y. Kuo Progression Award – Discovery Stage Research Projects Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8 $234,000
Neurona Therapeutics Dr. Cory R Nicholas Progression Award – Discovery Stage Research Projects Global gene expression profiling of single inhibitory neurons derived from human stem cells $202,500
Stanford University Professor Hiromitsu Nakauchi Progression Award – Discovery Stage Research Projects Using metabolic pausing for maintaining stable and high-quality pluripotent stem cells $208,422
Aspen Neuroscience Dr. Andres Bratt-Leal Progression Award – Discovery Stage Research Projects Autologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells $177,579
1 … 22 23 24 25 26 27 28 29 30 31 32